| Task Force Number | Task Force Name | Task Force Chairs |
|---|
| TF-2021-18 | Update of the International Multidisciplinary Classification of the Interstitial Pneumonias | Andrew Nicholson,
Chris Ryerson |
| TF-2021-17 | ERS Statement on preschool wheezing disorders: knowledge gaps, update definitions and outline future directions | Sejal Saglani,
Padmaja Subbarao |
| TF-2021-16 | ERS Clinical Practice Guidelines on diagnosis and management of Pulmonary Alveolar Proteinosis | Cormac McCarthy,
Francesco Bonella,
Elisabeth Bendstrup |
| TF-2021-14 | ERS Statement on transition of paediatric patients with interstitial lung disease to the adult care | Petr Pohunek,
Effrosyne Manali |
| TF-2021-10 | Core outcome set for trials evaluating the management of pneumonia – an ERS Statement | Timothy Felton,
Tobias Welte |
| TF-2021-09 | Developing Global Lung Function Initiative (GLI) reference equations for cardiopulmonary exercise testing (CPET) – an ERS Technical Standard | Karl Sylvester,
Helge Hebestreit |
| TF-2021-08 | ERS Clinical Practice Guidelines on Symptom Management in advanced lung disease | Anne Holland,
Magnus Ekström,
Natasha Smallwood |
| TF-2021-06 | ERS Statement on “Benign” Pleural Effusions | Najib Rahman,
Giuseppe Cardillo |
| TF-2021-05 | ERS Statement on Advanced Telemedicine for Sleep Disordered Breathing | Maria Bonsignore,
Johan Verbraecken |
| TF-2021-03 | ERS Clinical Practice Guideline on Weaning from Mechanical Ventilation | Martin Dres,
Paolo Navalesi |
| TF-2021-01 | ERS/EBMT Clinical Practice Guidelines on treatment of pulmonary chronic graft versus host disease | Robin Vos,
Daiana Stolz,
Saskia Bos |
| TF-2020-22 | ERS Guideline on ICS/formoterol on demand | Alberto Papi,
Florence Schleich,
Diogenes Ferreira |
| TF-2020-18 | ERS Technical Standard for a comprehensive high-quality lung cancer CT screening programme | David Baldwin,
Jan Van Meerbeeck |
| TF-2020-17 | ERS Statement on defining respiratory exacerbations for bronchiectasis in children and adolescents | Anne Chang,
Ahmad Kantar |
| TF-2020-15 | ERS Statement on frailty in adults with chronic lung disease | Matthew Maddocks,
Christian Osadnik |
| TF-2020-14 | ERS Guidelines for management of COVID-19 | Nicolas Roche,
James Chalmers |
| TF-2020-13 | ERS/ESC Guidelines on pulmonary hypertension | Marion Delcroix,
Stephan Rosenkranz |
| TF-2020-11 | ERS/ESTS Statement on management of pleural infection | Isabelle Schmitt-Opitz,
Najib Rahman,
Eihab Bedawi |
| TF-2020-10 | ERS Clinical Practice Guideline on various aspects of quality in lung cancer care | Torsten Blum,
Thierry Berghmans,
Adrian Constantini |
| TF-2020-07 | ERS/ESTS Clinical Practice Guideline Task Force on fitness for tumour-specific treatments of lung cancer | Alessandro Brunelli,
Huber Rodolfo Maria, Georgia Hardavella |
| TF-2020-06 | ERS Statement on dyspnoea: a multidimensional and multidisciplinary approach | Pierantonio Laveneziana,
Louis Laviolette |
| TF-2020-05 | ERS Statement on airway clearance techniques in adults with bronchiectasis | Arietta Spinou,
Beatriz Herrero-Cortina |
| TF-2020-03 | ERS/EULAR Clinical practice guideline on connective tissue diseases with interstitial lung (ILD) involvement | Katerina Antoniou,
Bruno Crestani,
Anna-Maria Hoffmann-Vold,
Oliver Distler |
| TF-2020-02 | Technical standard on nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesis | Jane Lucas,
Nicole Beydon |
| TF-2020-01 | Developing Global Lung Function Initiative (GLI) reference equations for multiple breath washout | Alexandre Horsley,
Kathryn Ramsey |
| TF-2019-21 | Updated Technical Standards for the measurement of lung volumes | Bhakta Nirav,
Aisling McGowan |
| TF-2019-18 | Idiopathic Pulmonary Fibrosis (IPF) – An update of diagnosis and treatment recommendations: Official ATS/ERS/JRS/ALAT Clinical Practice Guidelines | Ganesh Raghu,
Carey Thomson,
Martine Remy-Jardin,
Luca Richeldi |
| TF-2019-16 | Technical Standards on scoring of respiratory events using type III devices for the diagnosis of sleep disordered breathing in adults and children | Renata Riha,
Winfried Randerath |
| TF-2019-14 | ERS/ESTS/ESTRO/ESR/ESTI Statement on management of incidental findings from low-dose CT screening for lung cancer (MILCa) | David Baldwin,
Gilbert Massard |
| TF-2019-10 | A statement on the impact of genetics in pulmonary fibrosis | Raphael Borie,
Coline Van Moorsel |
| TF-2019-09 | Guidelines on transbronchial (cryo)biopsy and surgical lung biopsy in interstitial lung diseases | Venerino Poletti,
Jouke Annema |
| TF-2019-05 | Guidelines on management of spontaneous pneumothorax | Najib Rahman,
Guiseppe Cardillo |
| TF-2019-03 | Statement on dyspnoea in acutely ill mechanically ventilated patients | Alexandre Demoule,
Leo Heunks |
| TF-2018-15 | Statement on treatment of lung cancer stage 1A | Hans-Ulrich Kauczor,
Nir Peled |
| TF-2018-14 | Statement on Combined pulmonary fibrosis and emphysema (CPFE) | Vincent Cottin |
| TF-2018-08 | Statement on diagnosis and investigation of central sleep apnoea in children aged 1 month to 18 years | Hui-Leng Tan |
| TF-2018-07 | Techincal Standards on Developing Lung Function Initiative (GLI) reference equations for exhaled and nasal nitric oxide | Anh-Tuan Dinh-Xuan, Graham Hall |
| TF-2017-04 | ERS Statement for the Interpretation of Nitric Oxide Uptake in the Lung | Anh-Tuan Dinh-Xuan,
Gerald Zavorsky |
| TF-2017-03 | Guidelines on management of severe community acquired pneumonia | Antoni Torres,
Ignacio Martin-Loeches |
